Fields AL - Search Results

1

Continuous low-dose combined hormone replacement therapy and the risk of endometrial cancer.

Comerci JT Jr, Fields AL, Runowicz CD, Goldberg GL. Comerci JT Jr, et al. Among authors: fields al. Gynecol Oncol. 1997 Mar;64(3):425-30. doi: 10.1006/gyno.1996.4559. Gynecol Oncol. 1997. PMID: 9062144 Free article. Clinical Trial.

2

Evaluation of low-dose intraperitoneal interferon-alpha for palliation of ascites in patients with non-ovarian gynecologic malignancies.

Khabele D, Runowicz CD, Fields AL, Anderson PS, Goldberg GL. Khabele D, et al. Among authors: fields al. Gynecol Oncol. 2003 Jun;89(3):420-3. doi: 10.1016/s0090-8258(03)00080-5. Gynecol Oncol. 2003. PMID: 12798705

3

Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix.

Fields AL, Anderson PS, Goldberg GL, Wadler S, Beitler J, Sood B, Runowicz CD. Fields AL, et al. Gynecol Oncol. 1996 Jun;61(3):416-22. doi: 10.1006/gyno.1996.0166. Gynecol Oncol. 1996. PMID: 8641625 Clinical Trial.

4

Endometrioid adenocarcinoma of the ovary and long-term tamoxifen therapy: a coincidence or a cause for concern?

Kuo DY, Jones J, Fields AL, Runowicz CD, Goldberg GL. Kuo DY, et al. Among authors: fields al. Eur J Gynaecol Oncol. 1997;18(6):457-60. Eur J Gynaecol Oncol. 1997. PMID: 9443009

5

Colony-stimulating factor-1 and its receptor do not have a role in the pathogenesis of uterine sarcomas.

Anderson PS, Smith HO, Goldberg GL, Fields AL, Runowicz CD, Pollard JW. Anderson PS, et al. Among authors: fields al. Gynecol Oncol. 1999 Aug;74(2):202-7. doi: 10.1006/gyno.1999.5446. Gynecol Oncol. 1999. PMID: 10419732

6

Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.

Sood BM, Gorla G, Gupta S, Garg M, Deore S, Runowicz CD, Fields AL, Goldberg GL, Anderson PS, Vikram B. Sood BM, et al. Among authors: fields al. Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):702-6. doi: 10.1016/s0360-3016(02)02745-1. Int J Radiat Oncol Biol Phys. 2002. PMID: 12062615

7

Current therapies in ovarian cancer.

Fields AL, Runowicz CD. Fields AL, et al. Cancer Invest. 2003;21(1):148-56. doi: 10.1081/cnv-120016409. Cancer Invest. 2003. PMID: 12643016 Review. No abstract available.

8

Phase II trial of thalidomide for advanced and recurrent gynecologic sarcoma: a brief communication from the New York Phase II consortium.

Yi-Shin Kuo D, Timmins P, Blank SV, Fields AL, Goldberg GL, Murgo A, Christos P, Wadler S, Runowicz CD. Yi-Shin Kuo D, et al. Among authors: fields al. Gynecol Oncol. 2006 Jan;100(1):160-5. doi: 10.1016/j.ygyno.2005.08.033. Epub 2005 Sep 29. Gynecol Oncol. 2006. PMID: 16198398 Clinical Trial.

9

Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003).

Goldberg GL, Sukumvanich P, Einstein MH, Smith HO, Anderson PS, Fields AL. Goldberg GL, et al. Among authors: fields al. Gynecol Oncol. 2006 May;101(2):261-8. doi: 10.1016/j.ygyno.2005.10.011. Epub 2006 Jan 19. Gynecol Oncol. 2006. PMID: 16426668

10

Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer.

Novetsky AP, Einstein MH, Goldberg GL, Hailpern SM, Landau E, Fields AL, Mutyala S, Kalnicki S, Garg M. Novetsky AP, et al. Among authors: fields al. Gynecol Oncol. 2007 Jun;105(3):635-40. doi: 10.1016/j.ygyno.2007.01.032. Epub 2007 Feb 27. Gynecol Oncol. 2007. PMID: 17331568

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page